Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its ...

Long-acting therapies offer value for chronic disease, improving adherence and outcomes. This OHE report highlights HTA gaps, ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

Commonly used with injectable long-acting insulin. Regular or short-acting 30 min 2 to 3 hours 3 to 6 hours Taken with meals, typically 30 to 60 minutes before a meal. acting 2 to 4 hours 4 to 12 ...

The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin Tresiba (insulin degludec) got US approval late last year. [caption id ...

NVO stock gains after reporting first-quarter 2025 results, mainly due to expectations of U.S. sales recovery of its popular ...

Methods: In two randomized, open-label, placebo-controlled, five-period-crossover studies, patients with type 1 DM received preprandial injections of pramlintide, short-acting insulin, and long ...

As the name suggests, rapid-acting insulin starts to work pretty quickly in the bloodstream. You may experience hypoglycemia or low blood sugar if you wait too long to eat. Depending on the type ...

Short-acting insulin starts to work within 30 minutes and its effects last for 3 to 6 hours. Intermediate-acting insulin starts to work within 2 to 4 hours and lasts for 12 to 18 hours.

A new study has found that a group of diabetes drugs called SGLT2 inhibitors may increase the risk of a rare but dangerous ...

Managing high blood sugar is crucial for your health, especially if you're living with diabetes or prediabetes. While it can ...

Sioned and Fin, have challenged themselves and their relationship with the biggest test of all and spoke to us about ...